X0508 4 2024-08-07 0000887359 Vericel Corp VCEL 0001214938 MCLAUGHLIN KEVIN F C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true true Common Stock 2024-08-07 4 M 0 5000 3.74 A 16900 D Common Stock 2024-08-07 4 S 0 5000 45.92 D 11900 D Common Stock 2024-08-07 4 M 0 2000 3.74 A 13900 D Common Stock 2024-08-07 4 S 0 2000 45.99 D 11900 D Stock Option (Right to Buy) 3.74 2024-08-07 4 A 0 5000 0 A Common Stock 5000 0 D Stock Option (Right to Buy) 3.74 2024-08-07 4 A 0 2000 0 A Common Stock 2000 13000 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. /s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin 2024-08-09